Search results for "Highlights"
Previous gastroenteritis may be associated with later risk for IBD
In this Swedish case-control study, any previous GI infection and previous bacterial, parasitic, and viral GI infection were associated with higher risk for inflammatory bowel disease (IBD) versus controls.
https://gastroenterology.acponline.org/archives/2018/11/27/2.htm
27 Nov 2018
H. pylori treatment, supplements linked to improved gastric cancer outcomes
A randomized trial of high-risk patients in China found that Helicobacter pylori treatment, vitamin supplementation, and garlic supplementation were associated with significant reductions in gastric cancer mortality.
https://gastroenterology.acponline.org/archives/2019/09/27/1.htm
27 Sep 2019
Beta-blocker monotherapy may be preferred for primary prophylaxis of esophageal variceal bleeding
Guidelines currently recommend nonselective beta-blockers or variceal band ligation for primary prevention of variceal bleeding based on similar efficacy, but survival benefit may be better with the former treatment.
https://gastroenterology.acponline.org/archives/2018/08/24/2.htm
24 Aug 2018
Individual or group hypnotherapy associated with relief from IBS
Although hypnotherapy did not improve quality of life, psychological symptoms, cognition, self-efficacy, or irritable bowel syndrome (IBS) symptoms significantly more than an educational support program, it may provide relief to patients by changing their perception of IBS.
https://gastroenterology.acponline.org/archives/2018/12/28/3.htm
28 Dec 2018
Antidepressants may mitigate link between inflammatory bowel disease and depression
Patients with depression had more than double the risk of developing Crohn's disease or ulcerative colitis over a median follow-up of more than six years.
https://gastroenterology.acponline.org/archives/2018/10/26/3.htm
26 Oct 2018
USPSTF continues to recommend against screening for pancreatic cancer
There is no evidence that screening for pancreatic cancer or treating screen-detected disease improves disease-specific morbidity or all-cause mortality in average-risk adults with no symptoms, the U.S. Preventive Services Task Force (USPSTF) concluded.
https://gastroenterology.acponline.org/archives/2019/08/23/1.htm
23 Aug 2019
Statins associated with lower risk for postcolonoscopy colorectal cancer
The primary outcome of the retrospective cohort study was postcolonoscopy colorectal cancer within three years, defined as colorectal cancer diagnosed within six and 36 months after negative findings on index colonoscopy.
https://gastroenterology.acponline.org/archives/2019/03/22/3.htm
22 Mar 2019
Induction, maintenance therapies for ulcerative colitis compared
Oral sulfasalazine, diazo-bonded 5-aminosalicylates (5-ASAs), mesalazine, controlled ileal-release budesonide, and budesonide multimatrix, alone or in combination with rectal 5-ASA therapy, were assessed for comparative efficacy and tolerability.
https://gastroenterology.acponline.org/archives/2018/08/24/3.htm
24 Aug 2018
Boxed warning added to liver disease drug
The drug has been incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, which increases the risk of serious liver injury, the FDA said.
https://gastroenterology.acponline.org/archives/2018/02/23/7.htm
23 Feb 2018
CRC rates appear to be rising among younger adults in U.S., Europe
Two recent studies looked at changes in colorectal cancer (CRC) incidence over time, one in U.S. adults ages 40 to 49 years and one in European adults ages 20 to 49 years.
https://gastroenterology.acponline.org/archives/2019/05/24/1.htm
24 May 2019